CSF-1R/M-CSF-R Antibody 3152S from Cell Signaling Technology

Product Specs
ItemCSF-1R/M-CSF-R Antibody
CompanyCell Signaling Technology
Price $306.00 Inquire
Catalog Number3152S
Quantity100 µl
ApplicationsW
ReactivityH, M
TargetCSF1R
HostRabbit
NCBI Gene AliasesBANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, GPSC, HDLS, HDLS1, M-CSF-R
NCBI Full Gene Namecolony stimulating factor 1 receptor
ClonalityPolyclonal
Research AreaRTK
Molecular Weight52 cytoplasmic domain. 140 precursor. 175 M-CSF Receptor

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) CSF1R T567M mutation induces microglial dysfunction and synaptic impairment in patient iPSC-derived cerebral organoids of CSF1R-related disorderCell Death DiscoveryMarch 12, 2026Li Chi, Haitao Tu, Zhihong Li, Lifeng Qiu, Zhi-Wei Zhang, Sook-Yoong Chia, Jayne Yi Tan, Ivy A. W. Ho, Yuin-Han Loh, Eng-King Tan, et al.performed as previously described [75, 76]. The antibodies used in this study were CSF1R (Cell Signaling, #3152), phospho-CSF1R Tyr708 (Cell Signaling, #3080), phospho-CSF1R Tyr723 (Cell Signaling, #3151), phospho-CSF1R

(2) Microglia replacement by peripheral delivery of CSF1R inhibitor-resistant hematopoietic cellsMolecular TherapyFebruary 4, 2026Sonia I. Lombroso, Emily I. Church, Ryan N. Anderson, Carleigh A. O’Brien, Yixuan Zhu, Asif A. Dar, Freddy S. Purnell, Eli M. Levitt, Brian Temsamrit, Fazeela Yaqoob, et al.(Tyr723) (49C10) (1:1,000; CST, catalog no. 3155), rabbit CSF-1R/M-CSF-R (1:1,000; CST, catalog no. 3152), rabbit phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (1:1,000; CST, catalog no. 9101), and β-actin

(3) Isolation and Characterization of Peritoneal Macrophages from SalamandersMethods in Molecular BiologyJanuary 14, 2026Anthony Sallese, Georgios Tsissios, José Raúl Pérez-Estrada, Arielle Martinez, Katia Del Del Rio-Tsonis(Life technologies #D1306) at 1:1000. 2.2.2.6. Antibodies: 2.2.2.6.1. CSF1R antibody (Cell signaling #3152s) at 1:200 dilution. 2.2.2.6.2. iNOS antibody from (Abcam #ab3523) at 1:200 dilution. 2.2.2.6.3. Arginase

(4) Chemically-induced degradation of the endoplasmic-reticulum stress sensor IRE1 by a VHL-recruiting chimeraNat CommunDecember 11, 2025Jin Du, Elisia Villemure, Matthew Johnson, Caleigh Azumaya, Catarina J. Gaspar, Scot Marsters, David Lawrence, Scott Foster, Alexis Rohou, Tommy K. Cheung, et al.#2316), GSK-3α (D80E6) Rabbit mAb (Cell Signaling, #4337), CSF-1R/M-CSF-R Antibody (Cell Signaling, #3152), SAPK/JNK Antibody (Cell Signaling, #9252), JNK2 (56G8) Rabbit mAb (Cell Signaling, #9258), JNK3 (55A8) Rabbit mAb

(5) CSF1‐R inhibition attenuates posttraumatic osteoarthritis and quadriceps atrophy following ligament injuryThe Journal of PhysiologyDecember 1, 2025Alexander R. Keeble, Nicholas T. Thomas, Peyton J. Balawender, Camille R. Brightwell, Sara Gonzalez‐Velez, Madeline G. O'Daniel, Caitlin E. Conley, Austin V. Stone, Darren L. Johnson, Brian Noehren, et al.albumin solution and then incubated in primary antibody overnight with gentle agitation: anti-CSF1R (#3152; Cell Signaling, RRID:AB_2085233) or anti-MMP13 (#MAB13426; Millipore, RRID:AB_94144), both at 1:1,000.

(6) Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpressionJ Transl MedAugust 12, 2025Cheng Dai, Bin Shen, Shenyan Liu, Cong Li, Shuqun Yang, Jie Wang, Jie Zhang, Manqi Liu, Zhixuan Zhu, Wan Shi, et al.included CSF-1 (Proteintech, Cat# 14779-1-AP, RRID: AB_10643241), CSF-1R (Cell Signaling Technology, Cat# 3152, RRID: AB_2085233), phospho-CSF1-R (Cell Signaling Technology, Cat# 3155, RRID: AB_2085229), phospho-ERK1/2

(7) Macrophages with different origins proliferate ex vivo and do not lose their core intrinsic featuresiScienceJune 20, 2025Sara A. Habash, Naofumi Takahashi, Youssef M. Eltalkhawy, Randa A. Abdelnaser, Hiromi Ogata-Aoki, Seiji Okada, Hitoshi Takizawa, Shingo Usuki, Kan Etoh, Shinjiro Hino, et al.was performed as described previously.47 The antibodies used were as follows: anti-M-CSF receptor (#3152; Cell Signaling Technology), anti-pTyr809 M-CSF receptor (#3154; Cell Signaling Technology), anti-cleaved

(8) Targeting the IL34-CSF1R axis Improves Metastatic Renal Cell Carcinoma Therapy Outcome via Immune-Vascular Crosstalk RegulationiScienceJune 20, 2025Andrea Emanuelli, Wilfried Souleyreau, Tiffanie Chouleur, Bram Boeckx, Yasmine Pobiedonoscew, Lindsay Cooley, Marie-Alix Derieppe, Julie Martineau, Damien Ambrosetti, Jean-Christophe Bernhard, et al.anti-MRC1/CD206,bio-techne,AF2535; RRID:AB_2063012 Rabbit anti-GFP,MBL,598; RRID:AB_591816 Rabbit anti-CSF1R,Cell Signaling,#3152; RRID:AB_2085233 Rabbit anti-mouse IL34,antibodies-online,ABIN1175348; RRID: AB_3695706 Mouse anti-human

(9) Identification of TNFAIP2 as a unique cellular regulator of CSF-1 receptor activationLife Sci AllianceFebruary 12, 2025Randa A Abdelnaser, Masateru Hiyoshi, Naofumi Takahashi, Youssef M Eltalkhawy, Hidenobu Mizuno, Shunsuke Kimura, Koji Hase, Hiroshi Ohno, Kazuaki Monde, Akira Ono, et al.from Cell Signaling Technology), anti-phosphotyrosine (PY99; Santa Cruz Biotechnology), anti-CSF1R (#3152; Cell Signaling Technology) (to detect mouse CSF1R), anti-CSF1R (E7S2S; Cell Signaling Technology) (to

(10) Proinflammatory microglial activation impairs in vitro cortical tissue repair via zinc-dependent ADAM17 cleavage of the CSF-1 receptorJournal of neurochemistryFebruary 1, 2025Hernandez-Espinosa DR, Medina-Ruiz GI, Scrabis MG, Thathiah A, Aizenman E.anti-Iba1 (1:1;500; Cell signaling, #17198; RRID: AB_2820254), anti-CSF-1R (1:1000; Cell signaling, #3152; RRID: AB_2085233), anti-ADAM17 (Invitrogen, # MA5-32572), anti-MAP2 (1:1000; SYSY, 188-004, RRID: AB_2147096),

(11) CSF1-R inhibition attenuates posttraumatic osteoarthritis and quadriceps atrophy following ligament injuryJ PhysiolDecember 22, 2024Alexander R. Keeble, Nicholas T. Thomas, Peyton J. Balawender, Camille R. Brightwell, Sara Gonzalez-Velez, Madeline G. O’Daniel, Caitlin E. Conley, Austin V. Stone, Darren L. Johnson, Brian Noehren, et al.albumin solution and then incubated in primary antibody overnight with gentle agitation: anti-CSF1R (#3152; Cell Signaling, RRID:AB_2085233) or anti-MMP13 (#MAB13426; Millipore, RRID:AB_94144), both at 1:1,000.

(12) Deciphering glial contributions to CSF1R-related disorder via single-nuclear transcriptomic profiling: a case studyActa neuropathologica communicationsAugust 28, 2024Pan J, Fores-Martos J, Delpirou Nouh C, Jensen TD, Vallejo K, Cayrol R, Ahmadian S, Ashley EA, Greicius MD, Cobos I.Buffered Saline + 0.1% Tween 20 (TBST) and incubated with anti CSF-1R/M-CSF-R antibody (1:1000, CST #3152) and anti-beta Actin (1:25,000, Abcam Cat#ab49900) at 4 °C overnight. Then, they were washed and incubated

(13) Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastomaActa pharmaceutica Sinica. BDecember 1, 2023Liu Y, Zhan Z, Kang Z, Li M, Lv Y, Li S, Tong L, Feng F, Li Y, Zhang M, et al.blotted with primary antibodies. The following antibodies were used here: p-CSF1R (#3155S), CSF1R (#3152S), VEGFR-2 (#9698), p-AKT (#4060S), AKT (#9272S), ERK1/2 (#137F5), p-ERK1/2 (#4370), GAPDH (#5174) and

(14) Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial LocalizationbioRxivNovember 1, 2023Nir Ben-Chetrit, Xiang Niu, Jesus Sotelo, Ariel D. Swett, Vinagolu K. Rajasekhar, Maria S. Jiao, Caitlin M. Stewart, Priya Bhardwaj, Sanjay Kottapalli, Saravanan Ganesan, et al.(#79404), Notch Activated Targets Antibody Sampler Kit (#68309), phospho-SMAD2/3 (#8685), CSF-1R (#3152), phospho-AKT Ser473 (#4060), AKT (#9272) and phospho-ERK (#9101) were purchased from Cell Signaling. Cytokine

(15) Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaClinical cancer research : an official journal of the American Association for Cancer ResearchSeptember 1, 2023Flint AC, Mitchell DK, Angus SP, Smith AE, Bessler W, Jiang L, Mang H, Li X, Lu Q, Rodriguez B, et al.(S807/811) (#CST-8516, Cell Signaling Technology, RRID:AB_11178658, 1:100 dilution), murine CSF1R (#CST-3152, Cell Signaling Technology, RRID:AB_2085233, 1:100 dilution), and murine Ki67 (#ab16667, Abcam, RRID:AB_302459,

(16) Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFαCell & bioscienceJune 24, 2023Oppezzo A, Monney L, Kilian H, Slimani L, Maczkowiak-Chartois F, Rosselli F.The following antibodies were used for Western blot analysis: rabbit anti-M-CSFR (Cell Signaling, #3152), mouse anti-RANK (Santa Cruz, #sc-374360), mouse anti-NFATc1 (BioLegend, #649607), mouse anti-Cathepsin

(17) Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosisCell death & diseaseJune 8, 2023Hong SY, Lu YT, Chen SY, Hsu CF, Lu YC, Wang CY, Huang KL.(Roche Diagnostic, IN, USA). The antibodies used for immunoblotting against pY723-CSF1R (#3151), CSF1R (#3152), pY705-STAT3 (#9145), STAT3 (#9139), pS536-NFκB (#3033), NFκB (#8242), p-SMAD2/3 (#3108), SMAD2/3 (#8685),

(18) Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesisNat Cardiovasc ResJune 1, 2023Liu W, Yalcinkaya M, Maestre IF, Olszewska M, Ampomah PB, Heimlich JB, Wang R, Vela PS, Xiao T, Bick AG, et al.(1:100 dilution, catalog no. 9661s, Cell Signaling Technology); anti-CSFR (1:100 dilution, catalog no. 3152s, Cell Signaling Technology); anti-TREM2 (1:100 dilution, catalog no. 13483-1-AP, Proteintech); and anti-IL-1β

(19) Astragaloside IV improves renal function and alleviates renal damage and inflammation in rats with chronic glomerulonephritisTurkish Journal of BiologyJanuary 1, 2023DONG ZHANG, ZONGYING LI, YUAN GAO, HAILING SUNmembrane (EMD Millipore), blocked with 5% nonfat milk, and then blocked with primary antibodies CSF1 (3152, 1:1000, Cell Signaling Technology) and GAPDH (ab8245, 1:1000, Abcam). Afterward, goat antirabbit IgG

(20) A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor MicroenvironmentCancersOctober 2, 2022Jeon Y, Kang H, Yang Y, Park D, Choi B, Kim J, Kim J, Nam K.phospho-CSF1R(Tyr723) (Cell Signaling Technology; #3155S, clone 49C10), CSF1R (Cell Signaling Technology; #3152S), phospho-ERK1/2(Thr202/Tyr204) (Cell Signaling Technology; #4370S, clone D13.14.4E), ERK1/2 (Cell Signaling Technology

Be the First to Write a Review!

CSF-1R/M-CSF-R Antibody

CSF-1R/M-CSF-R Antibody from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (46)

Reviews

CSF-1R/M-CSF-R Antibody from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map